BRVE — Braveheart Bio Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Braveheart Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2025 December 31st | |
|---|---|
| Period Length: | 12 M |
| Source: | PROSPECTUS |
| Standards: | USG |
| Status: | Final |
| Net Income/Starting Line | -66.1 |
| Non-Cash Items | 0.176 |
| Other Non-Cash Items | |
| Changes in Working Capital | 63.9 |
| Change in Prepaid Expenses | |
| Change in Other Assets | |
| Change in Accounts Payable | |
| Change in Accrued Expenses | |
| Other Operating Cash Flow | |
| Cash from Operating Activities | -2.01 |
| Other Investing Cash Flow Items | -33.6 |
| Change in Net Investments | |
| Cash from Investing Activities | -33.6 |
| Financing Cash Flow Items | 125 |
| Other Financing Cash Flow | |
| Net Issuance / Retirement of Stock | |
| Cash from Financing Activities | 125 |
| Beginning Cash Balance | |
| Ending Cash Balance | |
| Net Change in Cash | 89.2 |